AbL Diagnostics SA
PAR:ABLD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
AbL Diagnostics SA
Cash & Cash Equivalents
AbL Diagnostics SA
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AbL Diagnostics SA
PAR:ABLD
|
Cash & Cash Equivalents
€846.4k
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-14%
|
|
|
Rexel SA
PAR:RXL
|
Cash & Cash Equivalents
€1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Jacquet Metals SA
PAR:JCQ
|
Cash & Cash Equivalents
€179m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
7%
|
|
|
Thermador Groupe SA
PAR:THEP
|
Cash & Cash Equivalents
€97m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Herige SA
PAR:ALHRG
|
Cash & Cash Equivalents
€53m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
13%
|
|
|
Gold by Gold SA
PAR:ALGLD
|
Cash & Cash Equivalents
€34.1k
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
-37%
|
|
AbL Diagnostics SA
Glance View
ABL Diagnostics SA engages in owning and renting railcars for the rail freight transportation. The company is headquartered in Suresnes, Ile-De-France. The firm also provides Commercial and Industrial Machinery and Equipment Rental and Leasing services.
See Also
What is AbL Diagnostics SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
846.4k
EUR
Based on the financial report for Jun 30, 2025, AbL Diagnostics SA's Cash & Cash Equivalents amounts to 846.4k EUR.
What is AbL Diagnostics SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-14%
Over the last year, the Cash & Cash Equivalents growth was -50%. The average annual Cash & Cash Equivalents growth rates for AbL Diagnostics SA have been -31% over the past three years , -35% over the past five years , and -14% over the past ten years .
